PHGDH and breast carcinoma: Phosphoglycerate dehydrogenase (PHGDH), the first rate-limiting enzyme in the serine synthesis pathway, is elevated in ~70% of ER- breast cancers, and PHGDH inhibition showed an anti-proliferative effect [103].